Shukra Pharmaceuticals Limited (BOM:524632)

Shukra Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 11, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	6,402	9,568	3,575	514	95	70
Market Cap Growth	167.65%	167.65%	595.01%	443.89%	35.73%	-4.81%
Enterprise Value	6,322	9,415	3,504	520	199	165
Last Close Price	14.62	21.85	8.03	1.15	0.31	0.23
PE Ratio	66.45	99.92	19.28	11.67	12.60	37.04
PS Ratio	17.40	26.00	4.68	0.87	0.46	0.62
PB Ratio	10.19	15.23	6.20	2.03	0.58	0.45
P/TBV Ratio	10.19	15.23	6.20	2.03	0.58	0.45
P/FCF Ratio	123.70	184.87	-	-	1.47	-
P/OCF Ratio	80.85	120.83	-	16.23	1.18	12.97
EV/Sales Ratio	17.18	25.59	4.58	0.88	0.97	1.47
EV/EBITDA Ratio	37.33	55.59	16.18	8.01	6.78	9.38
EV/EBIT Ratio	45.38	67.58	17.87	11.17	15.63	58.82
EV/FCF Ratio	122.16	181.91	-	-	3.09	-
Debt / Equity Ratio	0.07	0.07	0.06	0.20	0.21	0.63
Debt / EBITDA Ratio	0.25	0.25	0.15	0.78	1.15	5.57
Debt / FCF Ratio	0.81	0.81	-	-	0.52	-
Asset Turnover	0.45	0.45	1.00	1.08	0.58	0.32
Inventory Turnover	1.32	1.32	16.28	12.78	3.73	1.81
Quick Ratio	1.21	1.21	2.89	1.00	0.62	1.46
Current Ratio	3.79	3.79	3.97	1.25	1.28	2.28
Return on Equity (ROE)	15.90%	15.90%	44.70%	21.16%	4.70%	1.21%
Return on Assets (ROA)	10.58%	10.58%	16.04%	5.29%	2.25%	0.51%
Return on Capital (ROIC)	13.63%	13.63%	26.88%	11.62%	3.53%	0.72%
Return on Capital Employed (ROCE)	20.00%	20.00%	30.80%	14.40%	5.60%	1.00%
Earnings Yield	1.50%	1.00%	5.19%	8.57%	7.94%	2.70%
FCF Yield	0.81%	0.54%	-1.95%	-2.57%	68.08%	-18.00%
Dividend Yield	0.68%	-	1.24%	1.09%	4.06%	-
Payout Ratio	45.73%	45.73%	0.38%	1.65%	-	-
Buyback Yield / Dilution	0.60%	0.60%	-551.03%	-7.38%	-	-0.02%
Total Shareholder Return	1.28%	0.60%	-549.78%	-6.29%	4.06%	-0.02%

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.